The DOI matches its Crossref record.
THE CHOLINERGIC SYSTEM IN OLD AGE AND ALZHEIMER'S DISEASE
Open accessAbstract
Activities relating to the cholinergic system in post-mortem brain tissue have been examined in relation to ageing and Alzheimer-type pathology. As senile plaque numbers increased in non-demented and demented old people, activities of choline acetyltransferase and acetylcholinesterase decreased, butyrylcholinesterase increased and muscarinic receptor binding remained unchanged. The behaviour of these biochemical activities was further examined in relation to the ageing process in mentally normal people. Loss of choline acetyltransferase also occurred, to a lesser extent, with increasing age and muscarinic binding decreased but there was no age-related loss in acetylcholinesterase. These biochemical findings are discussed in relation to the possible involvement of the cholinergic system in 'normal' ageing and in Alzheimer's disease and are compatible with an extension of age-related nerve terminal changes to abnormalities of cholinergic processes in the disease itself.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
Panula, P., Chen, Y.-C., Priyadarshini, M., Kudo, H., Semenova, S., Sundvik, M., & Sallinen, V. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.010 · Cited by 453
Rossor, M. N., Emson, P. C., Mountjoy, C. Q., Roth, M., & Iversen, L. L. (1980) · Neuroscience Letters · doi:10.1016/0304-3940(80)90177-9 · Cited by 433
Anti-apoptosis gene, survivin, and prognosis of neuroblastoma
Adida, C., Berrebi, D., Peuchmaur, M., Reyes-Mugica, M., & Altieri, D. C. (1998) · The Lancet · doi:10.1016/s0140-6736(05)70294-4 · Cited by 415
Noradrenergic mechanisms in neurodegenerative diseases: a theory
Marien, M. R., Colpaert, F. C., & Rosenquist, A. C. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.02.002 · Cited by 414
Effectiveness of regional DTI measures in distinguishing Alzheimer’s disease, MCI, and normal aging
Nir, T. M., Jahanshad, N., Villalon-Reina, J. E., Toga, A. W., Jack, C. R., Weiner, M. W., & Thompson, P. M. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.07.006 · Cited by 348
Sharma, P., Srivastava, P., Seth, A., Tripathi, P. N., Banerjee, A. G., & Shrivastava, S. K. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.006 · Cited by 331
Mushtaq, G., Greig, N., Khan, J., & Kamal, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141023141545 · Cited by 331
The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system
Decker, M. W. (1987) · Brain Research Reviews · doi:10.1016/0165-0173(87)90007-5 · Cited by 323
Cholinergic function and Alzheimer's disease
Giacobini, E. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.935 · Cited by 283
Grothe, M., Heinsen, H., & Teipel, S. J. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.06.019 · Cited by 281
Diffusion tensor imaging in mild cognitive impairment and Alzheimerʼs disease: a review
Chua, T. C., Wen, W., Slavin, M. J., & Sachdev, P. S. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282f4594b · Cited by 273
Amyloid–cholinesterase interactions: Implications for Alzheimer’s disease
Inestrosa, N. C., Dinamarca, M. C., & Alvarez, A. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.06238.x · Cited by 261
Geula, C. (1998) · Neurology · doi:10.1212/wnl.51.1_suppl_1.s18 · Cited by 184
Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease
van Osch, L. A. D. M., Hogervorst, E., Combrinck, M., & Smith, A. D. (2004) · Neurology · doi:10.1212/01.wnl.0000128134.84230.9f · Cited by 146
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer’s disease
Thompson, S., Lanctôt, K. L., & Herrmann, N. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.5.425 · Cited by 109
Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease
Hunter, S., & Brayne, C. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.218 · Cited by 94
Schmidt, M., Eckardt, R., Scholtz, K., Neuner, B., von Dossow-Hanfstingl, V., Sehouli, J., Stief, C. G., Wernecke, K.-D., Spies, C. D., & PERATECS Group (2015) · PLOS ONE · doi:10.1371/journal.pone.0137824 · Cited by 87
Central Anticholinergic Hypersensitivity in Aging
Ray, P. G., Meador, K. J., Loring, D. W., Zamrini, E. W., Yang, X.-H., & Buccafusco, J. J. (1992) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/002383099200500203 · Cited by 75
Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD)
Scheef, L., Grothe, M. J., Koppara, A., Daamen, M., Boecker, H., Biersack, H., Schild, H. H., Wagner, M., Teipel, S., & Jessen, F. (2019) · NeuroImage: Clinical · doi:10.1016/j.nicl.2018.101612 · Cited by 63
Morgan, A. R., Turic, D., Jehu, L., Hamilton, G., Hollingworth, P., Moskvina, V., Jones, L., Lovestone, S., Brayne, C., Rubinsztein, D. C., et al. (2007) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30509 · Cited by 42
Metadata
- Authors
- PERRY, E. K.
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 1980
- Volume
- 9
- Issue
- 1
- Pages
- 1-8
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- OpenAlex
- W1980657066
- Cited by
- 247
- References
- 0
- FWCI
- 11.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.